表达O抗原多糖的减毒沙门菌二价疫苗可预防禽致病性大肠埃希菌O1和O2感染
研究构建表达APEC O2 O抗原基因簇(15.5 kb)的质粒pSS28,并在减毒沙门菌S740中验证表达。S740(pSS28)在鸡模型中诱导对O2的同源保护;将其与S740(pSS27)等体积混合制成二价疫苗,可诱导针对O1和O2 LPS的血清IgG和黏膜sIgA,促进调理和补体杀菌,并对O1和O2致死攻击均产生保护。
要点
- S740(pSS28)在鸡模型中诱导对APEC O2的同源保护。
- 二价疫苗S740(pSS27)+S740(pSS28)诱导抗O1和O2 LPS的血清IgG和黏膜sIgA。
- 二价疫苗抗体促进调理和补体杀菌,并对O1和O2致死攻击均产生保护。
核心结论
- 由S740(pSS27)和S740(pSS28)组成的二价疫苗是针对APEC O1和O2感染的有前景的候选疫苗。
研究设计与样本
- 构建含APEC O2 O抗原多糖基因簇(15.5 kb)的质粒pSS28,经Western blot验证在减毒沙门菌S740中的生物合成。
- S740(pSS28)在鸡模型中评估对野生型APEC O2攻击的同源保护。
- 将S740(pSS27)与S740(pSS28)等体积混合制成二价疫苗,免疫鸡并评估抗体应答和保护效果。
主要发现
- S740(pSS28)在鸡模型中诱导对强毒野生型APEC O2攻击的同源保护。
- 二价疫苗免疫鸡产生针对APEC O1和O2 LPS的血清IgG和黏膜sIgA抗体。
- 二价疫苗诱导的抗体促进调理作用、激发补体介导的杀菌活性,并对强毒APEC O1和O2致死攻击均产生保护。
关键数值与推荐
- 质粒pSS27编码APEC O1 O抗原基因簇,大小为10.8 kb。
- 质粒pSS28编码APEC O2 O抗原多糖基因簇,大小为15.5 kb。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Avian pathogenic Escherichia coli (APEC), a leading cause of avian airsacculitis and colibacillosis, is responsible for significant economic loss in the poultry industry. APEC serogroups O1, O2, and O78 are predominantly associated with disease. Lipopolysaccharide (LPS) O-antigen has been shown to be a potent antigen for inducing specific protective immune responses. Therefore, we sought to develop a multivalent polysaccharide vaccine to prevent most APEC infections. We previously reported the stable expression of plasmid pSS27 encoding the APEC O1 O-antigen gene cluster (10.8 kb) in attenuated Salmonella enterica serovar Typhimurium S740 provided excellent protection against APEC O1 challenge. In this study, the plasmid pSS28 harboring the APEC O2 O-antigen polysaccharide gene cluster (15.5 kb) was constructed. Biosynthesis of pSS28-encoded APEC O2 O-antigen in Salmonella vaccine strain S740 was validated by Western blot. The recombinant Salmonella vaccine strain S740 (pSS28) elicited homologous protection against virulent wild-type APEC O2 challenge in a chicken model. Furthermore, through equal-volume mixing the two monovalent vaccine strains S740 (pSS27) and S740 (pSS28), a bivalent vaccine candidate against both APEC O1 and O2 was developed. Immunization of chickens with the bivalent vaccine elicited production of serum IgG and mucosal sIgA antibodies against the LPS of both APEC O1 and O2. Moreover, antibodies induced by the bivalent vaccine promoted opsonization, provoked complement-mediated bactericidal activity, and elicited protection against lethal challenge with both virulent APEC O1 and O2 strains. These results demonstrate that the bivalent vaccine comprised of S740 (pSS27) and S740 (pSS28) is a promising vaccine candidate against APEC O1 and O2 infection.
引用
- Han Y, Liu Q, Willias S, et al. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection. Vaccine. 2018. PMID: 29358057. doi:10.1016/j.vaccine.2018.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。